CS433286A3 - Peptides with 1-amino-1-cycloalkane carboxylic acid - Google Patents
Peptides with 1-amino-1-cycloalkane carboxylic acidInfo
- Publication number
- CS433286A3 CS433286A3 CS864332A CS433286A CS433286A3 CS 433286 A3 CS433286 A3 CS 433286A3 CS 864332 A CS864332 A CS 864332A CS 433286 A CS433286 A CS 433286A CS 433286 A3 CS433286 A3 CS 433286A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- residue
- phenylalanine
- leucine
- alanine
- glycine
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 6
- 239000004471 Glycine Substances 0.000 abstract 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 3
- 235000004279 alanine Nutrition 0.000 abstract 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 239000004475 Arginine Chemical group 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical group OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical group NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Chemical group OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003368 amide group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Chemical group OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000004494 ethyl ester group Chemical group 0.000 abstract 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 abstract 1
- ANSUDRATXSJBLY-VKHMYHEASA-N methyl (2s)-2-amino-3-hydroxypropanoate Chemical compound COC(=O)[C@@H](N)CO ANSUDRATXSJBLY-VKHMYHEASA-N 0.000 abstract 1
- -1 p-toluenesulfonyl Chemical group 0.000 abstract 1
- 230000004962 physiological condition Effects 0.000 abstract 1
- BXRNXXXXHLBUKK-UHFFFAOYSA-N piperazine-2,5-dione Chemical group O=C1CNC(=O)CN1 BXRNXXXXHLBUKK-UHFFFAOYSA-N 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 abstract 1
- 230000002269 spontaneous effect Effects 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS864332A CS277405B6 (en) | 1986-06-12 | 1986-06-12 | Peptides with 1-amino-1-cycloalkane carboxylic acid |
| CA000537992A CA1308515C (en) | 1986-06-12 | 1987-05-26 | Peptide derivatives and processes for their preparation |
| DE3789729T DE3789729T2 (de) | 1986-06-12 | 1987-06-09 | Peptidderivate und Verfahren zu deren Herstellung. |
| EP87305065A EP0249434B1 (en) | 1986-06-12 | 1987-06-09 | Peptide derivatives and processes for their preparation |
| AT8787305065T ATE105300T1 (de) | 1986-06-12 | 1987-06-09 | Peptidderivate und verfahren zu deren herstellung. |
| JP62144207A JPH082916B2 (ja) | 1986-06-12 | 1987-06-11 | ペプチド誘導体類及びそれらの製造方法 |
| US07/062,300 US4898930A (en) | 1986-06-12 | 1987-06-12 | Peptide derivatives and processes for their preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS864332A CS277405B6 (en) | 1986-06-12 | 1986-06-12 | Peptides with 1-amino-1-cycloalkane carboxylic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS433286A3 true CS433286A3 (en) | 1992-08-12 |
| CS277405B6 CS277405B6 (en) | 1993-03-17 |
Family
ID=5385817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS864332A CS277405B6 (en) | 1986-06-12 | 1986-06-12 | Peptides with 1-amino-1-cycloalkane carboxylic acid |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4898930A (cs) |
| EP (1) | EP0249434B1 (cs) |
| JP (1) | JPH082916B2 (cs) |
| AT (1) | ATE105300T1 (cs) |
| CA (1) | CA1308515C (cs) |
| CS (1) | CS277405B6 (cs) |
| DE (1) | DE3789729T2 (cs) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2161282A1 (en) * | 1998-07-20 | 2010-03-10 | Ipsen Pharma | Peptide analogues of PACAP |
| RU2142813C1 (ru) * | 1999-03-25 | 1999-12-20 | НИИ наркологии МЗРФ | Тетрапептид trp-nle-asp-phenh-ch(ch3)2, обладающий анксиолитической активностью |
| CN1164611C (zh) * | 2002-06-17 | 2004-09-01 | 厦门大学 | 丙-谷二肽合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3704288A (en) * | 1970-04-16 | 1972-11-28 | Joseph A Skorcz | L-tyrosyl-1-aminocyclopentane-1-carbonyl-l-phenylalanine |
| NO774303L (no) * | 1976-12-28 | 1978-06-29 | Troponwerke Gmbh & Co Kg | Nye dehydrooligopeptider, fremgangsmaate til deres fremstilling samt deres anvendelse som legemiddel |
| US4278595A (en) * | 1979-12-10 | 1981-07-14 | Vega Laboratories, Inc. | Orally active MIF analogs with an effect on the central nervous system |
| US4690936A (en) * | 1980-03-05 | 1987-09-01 | University Of Miami | Anti-hypertensive agents |
| CS231227B1 (en) * | 1982-10-01 | 1984-10-15 | Evzen Kasafirek | 2,5-pierazindion derivatives |
| DE3300774A1 (de) * | 1983-01-12 | 1984-07-12 | Hoechst Ag, 6230 Frankfurt | Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung |
| EP0135429B1 (en) * | 1983-08-16 | 1992-03-18 | The University Of Georgia Research Foundation, Inc. | The synthesis of cyclopropane amino acids and peptides |
| AU589665B2 (en) * | 1985-08-14 | 1989-10-19 | G.D. Searle & Co. | Substituted dipeptide amides |
-
1986
- 1986-06-12 CS CS864332A patent/CS277405B6/cs not_active IP Right Cessation
-
1987
- 1987-05-26 CA CA000537992A patent/CA1308515C/en not_active Expired - Fee Related
- 1987-06-09 DE DE3789729T patent/DE3789729T2/de not_active Expired - Fee Related
- 1987-06-09 EP EP87305065A patent/EP0249434B1/en not_active Expired - Lifetime
- 1987-06-09 AT AT8787305065T patent/ATE105300T1/de not_active IP Right Cessation
- 1987-06-11 JP JP62144207A patent/JPH082916B2/ja not_active Expired - Lifetime
- 1987-06-12 US US07/062,300 patent/US4898930A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE3789729D1 (de) | 1994-06-09 |
| CS277405B6 (en) | 1993-03-17 |
| US4898930A (en) | 1990-02-06 |
| EP0249434A2 (en) | 1987-12-16 |
| EP0249434B1 (en) | 1994-05-04 |
| JPS633000A (ja) | 1988-01-07 |
| JPH082916B2 (ja) | 1996-01-17 |
| EP0249434A3 (en) | 1990-01-24 |
| ATE105300T1 (de) | 1994-05-15 |
| CA1308515C (en) | 1992-10-06 |
| DE3789729T2 (de) | 1994-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0073143B1 (en) | Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides | |
| EP0260118B1 (en) | Selective amidination of diamines | |
| KR870007947A (ko) | 황-함유 그룹에 의해 치환된 5-아미노-4-하이드록시 발레릴 유도체 및 그의 제조 방법 | |
| MY107319A (en) | Process for the preparation of cyclic amino acids, as well as intermediates. | |
| EP0456152A3 (en) | Peptidamides, their process of preparation and the agents containing these peptides as fibrin-thrombin clotting inhibitors | |
| EP0254080A3 (en) | Malonic acid derivatives and methods for their synthesis | |
| US4692437A (en) | Anti-hypertensive agents | |
| RU95112539A (ru) | Новый полипептид и фармацевтическая композиция против вич-инфекции | |
| IE51259B1 (en) | Angiotensin converting enzyme inhibitors | |
| ATE61567T1 (de) | Verfahren zur herstellung von n-alkylierten aminosaeuren und deren estern, verwendung zur synthese von carboxyalkyldipeptiden. | |
| CS433286A3 (en) | Peptides with 1-amino-1-cycloalkane carboxylic acid | |
| AU3510989A (en) | N-(5,6,7,8-tetrahydropyrido(2,3-d)pyrimidin-6-yl-alkanoyl) -glutamic acid derivatives | |
| IE45738L (en) | Peptide derivatives | |
| BE901307A (fr) | Nouveaux derives de la gonadoliberine et procede pour leur preparation. | |
| TW273553B (cs) | ||
| GB1463190A (en) | Tripeptides and process for their preparation | |
| ATE80380T1 (de) | Diastereoselektives verfahren zur herstellung von zwischenprodukten verwendbar zur peptidderivatensynthese. | |
| EP0346460B1 (en) | Purine derivatives having pharmacological action | |
| ATE46347T1 (de) | Immunostimulierende peptide. | |
| CA2251060A1 (en) | Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action | |
| ES2019545A6 (es) | Procedimiento de preparacion de n-alquil aminoacidos, dipeptidos y aminocompuestos ciclicos. | |
| UA42830C2 (uk) | Засіб для профілактики або лікування рестенозу, фармацевтичний препарат для лікування рестенозу, спосіб профілактики або лікування рестенозу | |
| IE51739B1 (en) | Anti-hypertensive agents | |
| GB2114561A (en) | Anti-hypertensive agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF00 | In force as of 2000-06-30 in czech republic | ||
| MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20000612 |